Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycobacterium tuberculosis: a model system for structural genomics.

Clare V Smith1, James C Sacchettini

  • 1Department of Biochemistry and Biophysics, Texas A and M University, College Station, TX 77843-2128, USA.

Current Opinion in Structural Biology
|December 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro cleavage requirements and specificities of mycobacterial RNase E.

Biochemical and biophysical research communications·2026
Same author

Deep learning for assay nuisance compound detection using a gated co-attention graph embedding model (CAGE-Fusion).

Journal of cheminformatics·2026
Same author

Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation.

EMBO molecular medicine·2026
Same author

Mycobacterium tuberculosis MutT4/RppH is an RNA pyrophosphohydrolase that forms condensate-like bodies and impacts mRNA degradation.

Nucleic acids research·2026
Same author

SuFEx-based antitubercular compound irreversibly inhibits Pks13.

Nature·2025
Same author

Elesclomol-copper therapy improves neurodevelopment in two children with Menkes disease.

The Journal of clinical investigation·2025
Same journal

Molecular crowding and amyloidogenic self-assembly: Emergent perspectives from modern computations.

Current opinion in structural biology·2026
Same journal

Recent advances in modeling and simulation of biological phenomena in crowded and cellular environments.

Current opinion in structural biology·2026
Same journal

Progress toward linking single-molecule behavior and condensate material properties.

Current opinion in structural biology·2026
Same journal

Tomogram exploration through template matching and deep learning.

Current opinion in structural biology·2026
Same journal

A comparative review of cryo-electron ptychography: Biological applications and future perspectives.

Current opinion in structural biology·2026
Same journal

Metabolic disruptions through a three-dimensional genomic lens.

Current opinion in structural biology·2026
See all related articles

Genomic research has significantly advanced Mycobacterium tuberculosis studies, enabling rational drug design and vaccine development against this persistent pathogen.

Area of Science:

  • Genomics
  • Proteomics
  • Structural Genomics

Background:

  • Mycobacterium tuberculosis research has been significantly impacted by advancements in genomics over the past five years.
  • The sequencing of virulent strains (H37Rv, CDC1551) and related strains positions M. tuberculosis as a model system for further research.

Purpose of the Study:

  • To leverage genomic data for the development of novel anti-tubercular drugs.
  • To explore the potential of structural genomics in understanding M. tuberculosis.
  • To aid in the development of an effective vaccine against tuberculosis.

Main Methods:

  • Comparative genomics of M. tuberculosis strains.
  • Proteomic analysis of M. tuberculosis.
  • High-resolution structural determination of drug targets.

Related Experiment Videos

Main Results:

  • Genomic data provides a foundation for M. tuberculosis research.
  • Structural information on drug targets is crucial for rational inhibitor design.
  • Novel protein folds are being identified.

Conclusions:

  • Genomics is revolutionizing tuberculosis research.
  • Structural genomics and proteomics offer promising avenues for drug discovery.
  • Advancements are critical for developing new tuberculosis treatments and vaccines.